• Pfizer Seeks Emergency Use Approval For COVID-19 Vaccine, Citing Promising Trial Results

    10 days ago - By PopSugar

    Days after announcing a 95 percent effectiveness rate for their COVID-19 vaccine, Pfizer and BioNTech are asking FDA regulators to approve the vaccine for emergency use in the US. If approved, the companies said shots could be available on a limited basis to high-risk individuals as early as mid- to late December.
    Pfizer and BioNTech are asking for emergency approval on the grounds that the vaccine has proven both safe to use and highly effective in clinical trials. The trials included 38,000 participants globally, covering a range of ages, races, and ethnicities, and to date, the...
    Read more ...

     

  • Yes, We Have COVID-19 Vaccines That Are 95% Effective. But That Doesn't Mean the End of the Pandemic is Near

    Yes, We Have COVID-19 Vaccines That Are 95% Effective. But That Doesn't Mean the End of the Pandemic is Near

    11 days ago - By Time

    It's a rare glimmer of hope in a brutal and battering pandemic year: in November, both Moderna and Pfizer reported that their much-anticipated COVID-19 vaccines are 95% effective in protecting people against getting sick with the disease.
    Scientists were encouraged (and even surprised by the magnitude of the protection), public health officials finally saw what could be the beginning of the end of the pandemic, and families everywhere began fantasizing about a return to normalcy where gathering around the table to celebrate the holidays are a given and not a matter of public health...
    Read more ...

     

  • Pfizer sends full results on breakthrough Covid vaccine to drugs watchdogs in UK, US and Europe

    Pfizer sends full results on breakthrough Covid vaccine to drugs watchdogs in UK, US and Europe

    11 days ago - By Daily Mail

    The American pharmaceutical giant - most famous for making Viagra - claims its vaccine is 95 per cent effective and works in older people most vulnerable to Covid.
    Read more ...